Shares of Afya Limited (NASDAQ:AFYA – Get Free Report) reached a new 52-week low during trading on Thursday . The company traded as low as $15.53 and last traded at $15.53, with a volume of 12921 shares trading hands. The stock had previously closed at $17.30.
Analyst Ratings Changes
Separately, UBS Group assumed coverage on Afya in a report on Friday, August 30th. They set a “neutral” rating and a $19.50 target price on the stock.
Check Out Our Latest Stock Report on Afya
Afya Stock Down 9.1 %
Afya (NASDAQ:AFYA – Get Free Report) last released its quarterly earnings data on Thursday, August 15th. The company reported $0.41 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.06. The firm had revenue of $155.40 million for the quarter, compared to analysts’ expectations of $151.83 million. Afya had a return on equity of 18.82% and a net margin of 18.12%. As a group, analysts anticipate that Afya Limited will post 1.52 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Afya
Several large investors have recently modified their holdings of the business. Marshall Wace LLP lifted its position in Afya by 41.8% in the second quarter. Marshall Wace LLP now owns 336,985 shares of the company’s stock valued at $5,948,000 after buying an additional 99,416 shares during the last quarter. Millennium Management LLC lifted its holdings in shares of Afya by 45.0% in the 2nd quarter. Millennium Management LLC now owns 291,164 shares of the company’s stock worth $5,139,000 after acquiring an additional 90,383 shares during the last quarter. Renaissance Technologies LLC boosted its position in shares of Afya by 19.7% during the 2nd quarter. Renaissance Technologies LLC now owns 266,500 shares of the company’s stock worth $4,704,000 after purchasing an additional 43,800 shares during the period. Cubist Systematic Strategies LLC increased its holdings in Afya by 136.9% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 35,254 shares of the company’s stock valued at $622,000 after purchasing an additional 20,370 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale purchased a new stake in Afya in the third quarter valued at approximately $417,000. Institutional investors and hedge funds own 88.02% of the company’s stock.
Afya Company Profile
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Read More
- Five stocks we like better than Afya
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
- What is a SEC Filing?
- Occidental Petroleum Hits New Low: Will Buffett Take the Bait?
- Which Wall Street Analysts are the Most Accurate?
- Top 3 R&D-Driven Stocks Showing Strong Profit and Momentum
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.